ARTICLE | Clinical News
Dura, Spiros regulatory update
November 9, 1998 8:00 AM UTC
The companies received a non-approvable letter from the FDA for their NDA for Albuterol Spiros, an inhaler powder form of the asthma drug albuterol. The FDA requested additional clinical trials on the...